PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24826N0054Illuccix — Telix Pharmaceuticals (Us) Inc

Telix Pharmaceuticals (Us) Inc holds $6.9M across 17 federal awards, concentrated at Department of Veterans Affairs (VA). Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

248-Network Contract Office 8 (36C248)

Awarding office

Telix Pharmaceuticals (Us) Inc

Recipient

Sep 30, 2026

PoP end

$1.8M

Obligated

$1.8M

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Telix Pharmaceuticals (Us) Inc — $90

Contract facts

Federal

Contract number36C24826N0054

Also listed as36C248-26-N-0054

Also listed as36E79722A0025-36C24826N0054

Agency248-Network Contract Office 8 (36C248)

Awarding office248-Network Contract Office 8 (36C248)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentTelix Pharmaceuticals (Us) Inc

CAGE8CP27

UEINMRHMBK4YTH7

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36E79722A0025

Place of performanceFISHERS IN

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startOct 1, 2025

PoP end (current)Sep 30, 2026

Obligated$1.8M

Current value$1.8M

Potential value$1.8M

ILLUCCIX is a federal award for 248-Network Contract Office 8 (36C248) held by Telix Pharmaceuticals (Us) Inc. Estimated value $1.8M ($1.8M obligated). Current period of performance ends Sep 30, 2026. Place of performance: FISHERS IN.

Recompete timing

Public

● Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Telix Pharmaceuticals (Us) Inc — $6.9M obligated across 17 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$6.9M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24826N0054?

36C24826N0054 (Illuccix) is a 248-Network Contract Office 8 (36C248) award with a potential value of $1.8M, currently held by Telix Pharmaceuticals (Us) Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C248-26-N-0054?

36C248-26-N-0054 is the dashed form of PIID 36C24826N0054 (Illuccix), held by Telix Pharmaceuticals (Us) Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24826N0054?

248-Network Contract Office 8 (36C248) awarded 36C24826N0054 to Telix Pharmaceuticals (Us) Inc (potential $1.8M).

Who is the incumbent on 36C24826N0054?

Telix Pharmaceuticals (Us) Inc is the incumbent with $6.9M across 17 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Telix Pharmaceuticals (Us) Inc’s 36C24826N0054 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Oct 1, 2025